🕵️ ZIVO Bioscience, Inc. ($ZIVO)
SEC insider & ownership activity, last 12 months · CIK 1101026 · every row links its SEC filing
Over the last 12 months insiders bought $1.5M with no open-market selling against it. Mark E. Strome bought $645K (Oct–Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
5 buyers, $1.5M (15 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark E. Strome | 5 | $645K | 0 | – | Apr 17, 2026 |
| Laith L. Yaldoo | 6 | $345K | 0 | – | Feb 27, 2026 |
| Christopher D. Maggiore | 2 | $299K | 0 | – | Jan 14, 2026 |
| Alison A. Cornell | 1 | $100K | 0 | – | Jan 26, 2026 |
| Payne John Bernard | 1 | $100K | 0 | – | Jan 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Mark E. Strome | 12.1% | 13D | Dec 31, 2025 | filing ↗ | |
| Strome Group, Inc. | 7.1% | 13D | Dec 31, 2025 | filing ↗ | |
| Strome Investment Management, LP | 7.1% | 13D | Dec 31, 2025 | filing ↗ | |
| Strome Mezzanine Fund II, LP | 6.8% | 13D | Dec 31, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Mar 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 19, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 12, 2025 | filing ↗ |